Unlike this gene, miR-106b-5p had an increased expression in the Cancer group, the same that presented low expression of TRAIL. Although the expression of these genes presents important statistical differences in the Cancer group, we confirmed that miR-106b-5p does not interfere directly in TRAIL but in genes activated from TRAIL signaling. The gene discussed is TNFSF10; the disease is cancer.